Amfetamine and methylphenidate medications for attention-deficit/hyperactivity disorder: complementary treatment options.
Attention-deficit/hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders among school-aged children. It is highly symptomatic and associated with significant impairment. This review examines the role of stimulant medications in the treatment of children and adolescents...
| Publicado en: | European Child & Adolescent Psychiatry Vol. 21; no. 9; pp. 477 - 493 |
|---|---|
| Autores principales: | , , , |
| Formato: | review tables/charts Journal Article |
| Publicado: |
Springer Nature
Sep2012
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104502028&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 104502028 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 10188827 EJ3 jtl: European Child & Adolescent Psychiatry issn: 10188827 maglogo: N pubinfo: dt: Sep2012 vid: 21 iid: 9 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 104502028 79614067 10.1007/s00787-012-0286-5 NLM22763750 PMC3432777 104502028 ppf: 477 ppct: 16 formats: fmt: @attributes: type: P tig: atl: Amfetamine and methylphenidate medications for attention-deficit/hyperactivity disorder: complementary treatment options. aug: au: Hodgkins, Paul Shaw, Monica Coghill, David Hechtman, Lily affil: Shire Pharmaceuticals, 725 Chesterbrook Boulevard Wayne 19087 USA sug: subj: Attention Deficit Hyperactivity Disorder Drug Therapy Central Nervous System Stimulants Therapeutic Use Amphetamine Pharmacodynamics Methylphenidate Pharmacodynamics Child Adolescence Human Clinical Assessment Tools Combined Modality Therapy Child: 6-12 years Adolescent: 13-18 years ab: Attention-deficit/hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders among school-aged children. It is highly symptomatic and associated with significant impairment. This review examines the role of stimulant medications in the treatment of children and adolescents with ADHD. Published clinical studies that compared methylphenidate- and amfetamine-based stimulants in children and adolescents with ADHD support the therapeutic utility of stimulant treatments, and suggest robust efficacy and acceptable safety outcomes in groups treated with either stimulant. Evidence-based guidelines agree that each patient with ADHD is unique and individual treatment strategies that incorporate both drug and non-drug treatment options should be sought. In seeking to optimize individual response and outcomes to stimulant therapy, important considerations include the selection of stimulant class, the choice of long- or short-acting stimulant formulations, addressing effectively any emergent adverse effects and strategies aimed at enhancing adherence to dosing regimen and persistence on therapy. pubtype: Academic Journal doctype: review tables/charts Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|